| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 11, 2022 | LFWD Lifeward Ltd. | Lind Global Fund II LP47 | 10% Owner | Buy | 180,030 | $0.85 | $153,037.46 | +0.7% | -1.7% | -10.0% | |
| Oct 10, 2022 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 6,725 | $85.00 | $571,625.00 | -9.7% | -7.7% | -11.9% | |
| Oct 10, 2022 | ANGO Angiodynamics Inc | Clemmer James C50 | President And CEO | Buy | 10,000 | $15.00 | $150,000.00 | +2.3% | +1.3% | -48.6% | |
| Oct 10, 2022 | STIM Neuronetics, Inc. | MacAn William Andrew66 | Sr. VP, GC, CCO And Secretary | Sell | 1,623 | $2.92 | $4,747.03 | -0.2% | +127.4% | -58.3% | |
| Oct 7, 2022 | PLSE Pulse Biosciences, Inc. | Levinson Mitchell E. | Chief Strategy Officer | Buy | 30,780 | $2.27 | $69,908.00 | +70.2% | +34.3% | +115.4% | |
| Oct 7, 2022 | BLFS Biolife Solutions Inc | De Greef Roderick74 | COO &President | Sell | 8,552 | $22.69 | $194,044.88 | -6.8% | -18.8% | -39.4% | |
| Oct 7, 2022 | CTKB Cytek Biosciences, Inc. | Jiang Wenbin75 | President And CEO | Sell | 20,000 | $14.79 | $295,800.00 | -0.3% | -29.3% | -63.5% | |
| Oct 7, 2022 | XTNT Xtant Medical Holdings, Inc. | Vizirgianakis Stavros G. | Director | Buy | 2,264,861 | $0.48 | $1,087,133.28 | +63.2% | -9.7% | +63.1% | |
| Oct 6, 2022 | NVCR Novocure Ltd | Leonard Frank X76 | President, Cns Cancers Us | Sell | 6,754 | $84.37 | $569,834.98 | -11.8% | -17.4% | -83.6% | |
| Oct 6, 2022 | TMCI Treace Medical Concepts, Inc. | Bays F Barry80 | Director | Sell | 29,774 | $22.85 | $680,323.13 | -0.9% | +1.5% | -47.8% | |
| Oct 4, 2022 | LFWD Lifeward Ltd. | Lind Global Fund II LP47 | 10% Owner | Buy | 9,896 | $0.90 | $8,876.91 | - | -17.0% | -20.2% | |
| Oct 3, 2022 | ARAY Accuray Inc | Chew Jesse57 | SVP, General Counsel | Sell | 8,995 | $2.10 | $18,878.71 | -3.4% | -5.0% | +19.3% | |
| Oct 3, 2022 | ARAY Accuray Inc | Winter Suzanne C63 | President | Sell | 17,060 | $2.10 | $35,805.53 | -2.2% | -5.0% | +19.3% | |
| Oct 3, 2022 | ARAY Accuray Inc | Hoge Michael68 | Senior VP Global Operations | Sell | 8,324 | $2.10 | $17,470.41 | -2.8% | -5.0% | +19.3% | |
| Oct 3, 2022 | ARAY Accuray Inc | Spine Patrick62 | SVP, Chief Admin Officer | Sell | 5,843 | $2.10 | $12,263.29 | -2.6% | -5.0% | +19.3% | |
| Oct 3, 2022 | PODD Insulet Corp | Petrovic Shacey56 | Director | Sell | 15,000 | $231.80 | $3,477,000.00 | -52.3% | +22.9% | -32.7% | |
| Oct 3, 2022 | NEOG Neogen Corp | Boehm William T67 | Director | Buy | 2,000 | $13.89 | $27,770.00 | +9.4% | +9.6% | +25.6% | |
| Oct 3, 2022 | BLFS Biolife Solutions Inc | De Greef Roderick74 | COO &President | Sell | 1,233 | $21.95 | $27,064.35 | -1.0% | -20.3% | -38.2% | |
| Oct 3, 2022 | RMD Resmed Inc | Pendarvis David68 | Chief Administrative Officer | Sell | 1,545 | $220.19 | $340,193.55 | -1.5% | -6.6% | -35.4% | |
| Oct 3, 2022 | TMDX Transmedics Group, Inc. | Carey John F | VP Of Operations | Sell | 3,000 | $42.09 | $126,266.00 | -57.4% | +35.2% | +22.4% | |
| Oct 3, 2022 | PEN Penumbra Inc | Sarna Surbhi67 | Director | Sell | 28 | $191.20 | $5,353.60 | -1.4% | +13.1% | +19.0% | |
| Oct 3, 2022 | MXCT Maxcyte, Inc. | Casdin Partners Master Fund, L.P.53 | 10% Owner | Sell | 735,786 | $6.15 | $4,525,083.90 | -6.9% | -26.5% | -57.0% | |
| Oct 3, 2022 | PEN Penumbra Inc | Wilder Thomas57 | Director | Sell | 124 | $191.20 | $23,708.80 | -26.8% | +13.1% | +19.0% | |
| Oct 3, 2022 | TMDX Transmedics Group, Inc. | Gordon Stephen52 | Chief Financial Officer | Sell | 10,000 | $41.74 | $417,400.00 | -63.6% | +35.2% | +22.4% | |
| Oct 3, 2022 | BSX Boston Scientific Corp | Mahoney Michael F57 | Chairman, President &CEO | Sell | 125,827 | $39.34 | $4,949,556.04 | -6.6% | +15.4% | +29.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.